The Patent Amendment (Human Genes and Biological Materials) Bill: No Barrier to Biotech Patenting.

The article offers the author's insights on the Patent Amendment (Human Genes and Biological Materials) Bill that was introduced to the Australian Senate in 2010 which aims to ban gene patents. Professor Ian Frazer wrote that if the bill has been enacted, it will prevent development of new products of biomedical research. The author mentions that the origin of the problem is a common statement by the patent offices of the U.S., the European Union (EU), and Japan that was released in June 1988. He argues that the proposition relies on a conventional legal precedent, and is false in relation with law. Moreover, the U.S. government, under its existing patent law, consents that biological materials which have been secluded from their natural environments are not patentable subject matter.